Central African Republic vs Guinea-Bissau: Statin use vs average non hdl cholesterol levels
Central African Republic
2.8
in 2018
Guinea-Bissau
2.8
in 2018
Central African Republic rank
161st
Guinea-Bissau rank
161st
Statin use vs average non hdl cholesterol levels over time
- Central African Republic
- Guinea-Bissau
How they compare
Central African Republic currently reports 2.8 against 2.8 in Guinea-Bissau, a difference of 0.
The two have swapped places 3 times across 39 shared years of data; in 1980 it was Central African Republic ahead.
Central African Republic ranks 161st and Guinea-Bissau ranks 161st of 189 countries.
Central African Republic has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Central African Republic | Guinea-Bissau | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 2.67 | 2.41 | 0.26 | Central African Republic |
| 1990s | 2.7 | 2.59 | 0.11 | Central African Republic |
| 2000s | 2.78 | 2.7 | 0.08 | Central African Republic |
| 2010s | 2.8 | 2.8 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher statin use vs average non hdl cholesterol levels, Central African Republic or Guinea-Bissau?
- Central African Republic, at 2.8 against 2.8 in Guinea-Bissau as of 2018.
- What is the difference in statin use vs average non hdl cholesterol levels between Central African Republic and Guinea-Bissau?
- 0, with Central African Republic ahead.
- How many years of comparable data are there for Central African Republic and Guinea-Bissau?
- 39 years are reported by both, from 1980 to 2018.
- How do Central African Republic and Guinea-Bissau rank globally for statin use vs average non hdl cholesterol levels?
- Central African Republic ranks 161st and Guinea-Bissau ranks 161st of 189 countries.
- Where does this data come from?
- Our World in Data, published as Statin use vs average non hdl cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.